201 related articles for article (PubMed ID: 31863971)
1. Structural and functional basis for increased HDL-cholesterol levels due to the naturally occurring V19L mutation in human apolipoprotein A-I.
Gkolfinopoulou C; Bourtsala A; Chroni A
Biochim Biophys Acta Mol Cell Biol Lipids; 2020 Mar; 1865(3):158593. PubMed ID: 31863971
[TBL] [Abstract][Full Text] [Related]
2. Structure-function analysis of naturally occurring apolipoprotein A-I L144R, A164S and L178P mutants provides insight on their role on HDL levels and cardiovascular risk.
Gkolfinopoulou C; Soukou F; Dafnis I; Kellici TF; Sanoudou D; Mavromoustakos T; Stratikos E; Chroni A
Cell Mol Life Sci; 2021 Feb; 78(4):1523-1544. PubMed ID: 32666307
[TBL] [Abstract][Full Text] [Related]
3. Effect of apoA-I Mutations in the Capacity of Reconstituted HDL to Promote ABCG1-Mediated Cholesterol Efflux.
Daniil G; Zannis VI; Chroni A
PLoS One; 2013; 8(6):e67993. PubMed ID: 23826352
[TBL] [Abstract][Full Text] [Related]
4. The effects of mutations in helices 4 and 6 of ApoA-I on scavenger receptor class B type I (SR-BI)-mediated cholesterol efflux suggest that formation of a productive complex between reconstituted high density lipoprotein and SR-BI is required for efficient lipid transport.
Liu T; Krieger M; Kan HY; Zannis VI
J Biol Chem; 2002 Jun; 277(24):21576-84. PubMed ID: 11882653
[TBL] [Abstract][Full Text] [Related]
5. Role of apoA-I, ABCA1, LCAT, and SR-BI in the biogenesis of HDL.
Zannis VI; Chroni A; Krieger M
J Mol Med (Berl); 2006 Apr; 84(4):276-94. PubMed ID: 16501936
[TBL] [Abstract][Full Text] [Related]
6. Substitutions of glutamate 110 and 111 in the middle helix 4 of human apolipoprotein A-I (apoA-I) by alanine affect the structure and in vitro functions of apoA-I and induce severe hypertriglyceridemia in apoA-I-deficient mice.
Chroni A; Kan HY; Kypreos KE; Gorshkova IN; Shkodrani A; Zannis VI
Biochemistry; 2004 Aug; 43(32):10442-57. PubMed ID: 15301543
[TBL] [Abstract][Full Text] [Related]
7. Lipidation of apolipoprotein A-I by ATP-binding cassette transporter (ABC) A1 generates an interaction partner for ABCG1 but not for scavenger receptor BI.
Lorenzi I; von Eckardstein A; Radosavljevic S; Rohrer L
Biochim Biophys Acta; 2008; 1781(6-7):306-13. PubMed ID: 18485926
[TBL] [Abstract][Full Text] [Related]
8. Structure-function relationships in reconstituted HDL: Focus on antioxidative activity and cholesterol efflux capacity.
Cukier AMO; Therond P; Didichenko SA; Guillas I; Chapman MJ; Wright SD; Kontush A
Biochim Biophys Acta Mol Cell Biol Lipids; 2017 Sep; 1862(9):890-900. PubMed ID: 28529180
[TBL] [Abstract][Full Text] [Related]
9. The carboxyl-terminal hydrophobic residues of apolipoprotein A-I affect its rate of phospholipid binding and its association with high density lipoprotein.
Laccotripe M; Makrides SC; Jonas A; Zannis VI
J Biol Chem; 1997 Jul; 272(28):17511-22. PubMed ID: 9211897
[TBL] [Abstract][Full Text] [Related]
10. Adipocyte modulation of high-density lipoprotein cholesterol.
Zhang Y; McGillicuddy FC; Hinkle CC; O'Neill S; Glick JM; Rothblat GH; Reilly MP
Circulation; 2010 Mar; 121(11):1347-55. PubMed ID: 20212278
[TBL] [Abstract][Full Text] [Related]
11. Naturally occurring and bioengineered apoA-I mutations that inhibit the conversion of discoidal to spherical HDL: the abnormal HDL phenotypes can be corrected by treatment with LCAT.
Koukos G; Chroni A; Duka A; Kardassis D; Zannis VI
Biochem J; 2007 Aug; 406(1):167-74. PubMed ID: 17506726
[TBL] [Abstract][Full Text] [Related]
12. Apolipoprotein A-IFIN (Leu159-->Arg) mutation affects lecithin cholesterol acyltransferase activation and subclass distribution of HDL but not cholesterol efflux from fibroblasts.
Miettinen HE; Jauhiainen M; Gylling H; Ehnholm S; Palomäki A; Miettinen TA; Kontula K
Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):3021-32. PubMed ID: 9409289
[TBL] [Abstract][Full Text] [Related]
13. N-terminal mutation of apoA-I and interaction with ABCA1 reveal mechanisms of nascent HDL biogenesis.
Liu M; Mei X; Herscovitz H; Atkinson D
J Lipid Res; 2019 Jan; 60(1):44-57. PubMed ID: 30249788
[TBL] [Abstract][Full Text] [Related]
14. Structural determinants in ApoA-I amyloidogenic variants explain improved cholesterol metabolism despite low HDL levels.
Del Giudice R; Domingo-Espín J; Iacobucci I; Nilsson O; Monti M; Monti DM; Lagerstedt JO
Biochim Biophys Acta Mol Basis Dis; 2017 Dec; 1863(12):3038-3048. PubMed ID: 28887204
[TBL] [Abstract][Full Text] [Related]
15. Significance of the hydrophobic residues 225-230 of apoA-I for the biogenesis of HDL.
Fotakis P; Tiniakou I; Kateifides AK; Gkolfinopoulou C; Chroni A; Stratikos E; Zannis VI; Kardassis D
J Lipid Res; 2013 Dec; 54(12):3293-302. PubMed ID: 24123812
[TBL] [Abstract][Full Text] [Related]
16. A key point mutation (V156E) affects the structure and functions of human apolipoprotein A-I.
Cho KH; Jonas A
J Biol Chem; 2000 Sep; 275(35):26821-7. PubMed ID: 10858436
[TBL] [Abstract][Full Text] [Related]
17. Effect of apolipoprotein A-I lipidation on the formation and function of pre-beta and alpha-migrating LpA-I particles.
Sparks DL; Frank PG; Braschi S; Neville TA; Marcel YL
Biochemistry; 1999 Feb; 38(6):1727-35. PubMed ID: 10026251
[TBL] [Abstract][Full Text] [Related]
18. The lipidation status of acute-phase protein serum amyloid A determines cholesterol mobilization via scavenger receptor class B, type I.
Marsche G; Frank S; Raynes JG; Kozarsky KF; Sattler W; Malle E
Biochem J; 2007 Feb; 402(1):117-24. PubMed ID: 17034364
[TBL] [Abstract][Full Text] [Related]
19. Small discoidal pre-beta1 HDL particles are efficient acceptors of cell cholesterol via ABCA1 and ABCG1.
Favari E; Calabresi L; Adorni MP; Jessup W; Simonelli S; Franceschini G; Bernini F
Biochemistry; 2009 Nov; 48(46):11067-74. PubMed ID: 19839639
[TBL] [Abstract][Full Text] [Related]
20. An apoA-I mimetic peptide facilitates off-loading cholesterol from HDL to liver cells through scavenger receptor BI.
Song X; Fischer P; Chen X; Burton C; Wang J
Int J Biol Sci; 2009 Oct; 5(7):637-46. PubMed ID: 19847320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
